<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lampe FC</submitter><funding>NIAID NIH HHS</funding><funding>Medical Research Council</funding><pagination>2337-2350</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6882545</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(15)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Antiretroviral treatment (ART) reduces HIV infectiousness but the effect of early ART on sexual behaviour is unclear.&lt;h4>Methods&lt;/h4>We assessed, within the START randomized trial that enrolled HIV-positive adults with CD4 cell count greater than 500 cells/μl, the effect of early (immediate) versus deferred ART on: condomless sex with HIV-serodifferent partners (CLS-D); all condomless sex (CLS); HIV transmission-risk sex (CLS-D-HIV risk, defined as CLS-D and: not on ART or started ART &lt;6 months ago or viral load greater than 200 copies/ml or no viral load in past 6 months), during 2-year follow-up. Month-12 CLS-D (2010-2014) was the primary outcome.&lt;h4>Results&lt;/h4>Among 2562 MSM, there was no difference between immediate and deferred arms in CLS-D at month 12 [12.6 versus 13.1%; difference (95% CI): -0.4% (-3.1 to 2.2%), P = 0.75] or month 24, or in CLS. Among 2010 heterosexual men and women, CLS-D at month 12 tended to be higher in the immediate versus deferred arm [10.8 versus 8.3%; difference:2.5% (-0.1 to 5.2%), P = 0.062]; the difference was greater at month 24 [9.3 versus 5.6%; difference: 3.7% (1.0 to 6.4%), P = 0.007], at which time CLS was higher in the immediate arm (20.7 versus 15.7%, P = 0.013). CLS-D-HIV risk at month 12 was substantially lower in the immediate versus deferred arm for MSM [0.2 versus 11%; difference: -10.7% (-12.5 to -8.9%), P &lt; 0.001] and heterosexuals [0.6% versus 7.7%; difference: -7.0% (-8.8 to -5.3%), P &lt; 0.001], because of viral suppression on ART.&lt;h4>Conclusion&lt;/h4>A strategy of early ART had no effect on condomless sex with HIV-serodifferent partners among MSM, but resulted in modestly higher prevalence among heterosexuals. However, among MSM and heterosexuals, early ART resulted in a substantial reduction in HIV-transmission-risk sex, to a very low absolute level.</pubmed_abstract><journal>AIDS (London, England)</journal><pubmed_title>Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison.</pubmed_title><pmcid>PMC6882545</pmcid><funding_grant_id>MC_UU_12023/23</funding_grant_id><funding_grant_id>UM1 AI068641</funding_grant_id><funding_grant_id>UM1 AI120197</funding_grant_id><funding_grant_id>U01 AI136780</funding_grant_id><pubmed_authors>INSIGHT START Study Group</pubmed_authors><pubmed_authors>Friedland G</pubmed_authors><pubmed_authors>Corbelli GM</pubmed_authors><pubmed_authors>Emery S</pubmed_authors><pubmed_authors>Barbosa de Souza M</pubmed_authors><pubmed_authors>Ruxrungtham K</pubmed_authors><pubmed_authors>Burman W</pubmed_authors><pubmed_authors>Molina JM</pubmed_authors><pubmed_authors>Gatell J</pubmed_authors><pubmed_authors>Sadr WE</pubmed_authors><pubmed_authors>Grulich A</pubmed_authors><pubmed_authors>Orkin C</pubmed_authors><pubmed_authors>Phillips AN</pubmed_authors><pubmed_authors>Gerstoft J</pubmed_authors><pubmed_authors>Lampe FC</pubmed_authors><pubmed_authors>Neaton J</pubmed_authors><pubmed_authors>Rodger AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison.</name><description>&lt;h4>Background&lt;/h4>Antiretroviral treatment (ART) reduces HIV infectiousness but the effect of early ART on sexual behaviour is unclear.&lt;h4>Methods&lt;/h4>We assessed, within the START randomized trial that enrolled HIV-positive adults with CD4 cell count greater than 500 cells/μl, the effect of early (immediate) versus deferred ART on: condomless sex with HIV-serodifferent partners (CLS-D); all condomless sex (CLS); HIV transmission-risk sex (CLS-D-HIV risk, defined as CLS-D and: not on ART or started ART &lt;6 months ago or viral load greater than 200 copies/ml or no viral load in past 6 months), during 2-year follow-up. Month-12 CLS-D (2010-2014) was the primary outcome.&lt;h4>Results&lt;/h4>Among 2562 MSM, there was no difference between immediate and deferred arms in CLS-D at month 12 [12.6 versus 13.1%; difference (95% CI): -0.4% (-3.1 to 2.2%), P = 0.75] or month 24, or in CLS. Among 2010 heterosexual men and women, CLS-D at month 12 tended to be higher in the immediate versus deferred arm [10.8 versus 8.3%; difference:2.5% (-0.1 to 5.2%), P = 0.062]; the difference was greater at month 24 [9.3 versus 5.6%; difference: 3.7% (1.0 to 6.4%), P = 0.007], at which time CLS was higher in the immediate arm (20.7 versus 15.7%, P = 0.013). CLS-D-HIV risk at month 12 was substantially lower in the immediate versus deferred arm for MSM [0.2 versus 11%; difference: -10.7% (-12.5 to -8.9%), P &lt; 0.001] and heterosexuals [0.6% versus 7.7%; difference: -7.0% (-8.8 to -5.3%), P &lt; 0.001], because of viral suppression on ART.&lt;h4>Conclusion&lt;/h4>A strategy of early ART had no effect on condomless sex with HIV-serodifferent partners among MSM, but resulted in modestly higher prevalence among heterosexuals. However, among MSM and heterosexuals, early ART resulted in a substantial reduction in HIV-transmission-risk sex, to a very low absolute level.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2024-11-20T15:02:46.294Z</modification><creation>2020-05-22T08:40:08Z</creation></dates><accession>S-EPMC6882545</accession><cross_references><pubmed>31764099</pubmed><doi>10.1097/QAD.0000000000002359</doi></cross_references></HashMap>